{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:08Z","timestamp":1791685388107,"version":"4.3.4"},"reference-count":82,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamaneurol.2018.4304","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T11:43:47Z","timestamp":1547466227000},"page":"420","source":"Crossref","is-referenced-by-count":246,"title":["Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease"],"prefix":"10.1001","volume":"76","author":[{"given":"Dilan","family":"Athauda","sequence":"first","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, University College London Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Gulyani","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanuma kumar","family":"Karnati","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Li","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweedie","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mustapic","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Chawla","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashfia","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"University College London Comprehensive Clinical Trials Unit, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Skene","sequence":"additional","affiliation":[{"name":"University College London Comprehensive Clinical Trials Unit, London, United Kingdom"},{"name":"School of Biosciences and Medicine, University of Surrey, Kent, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kapogiannis","sequence":"additional","affiliation":[{"name":"Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Foltynie","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, University College London Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi180098r1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma Extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes.","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front Neurosci"},{"issue":"4","key":"noi180098r2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.mcn.2005.12.003","article-title":"Exosomes are released by cultured cortical neurones.","volume":"31","author":"Faur\u00e9","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"noi180098r3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2012.00124","article-title":"Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?","volume":"3","author":"Bellingham","year":"2012","journal-title":"Front Physiol"},{"issue":"6","key":"noi180098r4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study.","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"12","key":"noi180098r5","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease.","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J"},{"issue":"5","key":"noi180098r6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal a-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease.","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"2","key":"noi180098r7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jnnp-2016-314601","article-title":"Neuroendocrine abnormalities in Parkinson\u2019s disease.","volume":"88","author":"De Pablo-Fern\u00e1ndez","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi180098r8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnagi.2016.00065","article-title":"Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson\u2019s disease.","volume":"8","author":"Song","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"Pt 2","key":"noi180098r9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson\u2019s disease, insulin resistance and novel agents of neuroprotection.","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"noi180098r10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?","volume":"118","author":"Bassil","year":"2014","journal-title":"Prog Neurobiol"},{"issue":"10","key":"noi180098r11","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2337\/dc08-0688","article-title":"Prospective cohort study of type 2 diabetes and the risk of Parkinson\u2019s disease.","volume":"31","author":"Driver","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"noi180098r12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc10-1333","article-title":"Diabetes and the risk of developing Parkinson\u2019s disease in Denmark.","volume":"34","author":"Schernhammer","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"noi180098r13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2337\/dc10-1922","article-title":"Diabetes and risk of Parkinson\u2019s disease.","volume":"34","author":"Xu","year":"2011","journal-title":"Diabetes Care"},{"key":"noi180098r14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2008.08.089","article-title":"Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson\u2019s disease.","volume":"1240","author":"Morris","year":"2008","journal-title":"Brain Res"},{"key":"noi180098r15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.","volume":"67","author":"Arnold","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"6","key":"noi180098r16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.freeradbiomed.2004.12.008","article-title":"Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.","volume":"38","author":"Choi","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"noi180098r17","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"noi180098r18","doi-asserted-by":"publisher","first-page":"R1082","DOI":"10.1152\/ajpregu.00449.2010","article-title":"Neurodegeneration in an animal model of Parkinson\u2019s disease is exacerbated by a high-fat diet.","volume":"299","author":"Morris","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"noi180098r19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.expneurol.2011.06.005","article-title":"Insulin resistance impairs nigrostriatal dopamine function.","volume":"231","author":"Morris","year":"2011","journal-title":"Exp Neurol"},{"key":"noi180098r20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2013.11.001","article-title":"Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.","volume":"251","author":"Wang","year":"2014","journal-title":"Exp Neurol"},{"key":"noi180098r21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson\u2019s disease: a new target for disease modification?","volume":"145-146","author":"Athauda","year":"2016","journal-title":"Prog Neurobiol"},{"key":"noi180098r22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2015.03.006","article-title":"Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1\/S6K1 signaling.","volume":"64","author":"Gao","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"noi180098r23","doi-asserted-by":"publisher","first-page":"12531","DOI":"10.1038\/srep12531","article-title":"Insulin-degrading enzyme prevents a-synuclein fibril formation in a nonproteolytical manner.","volume":"5","author":"Sharma","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"noi180098r24","first-page":"67","article-title":"p38 MAPK and PI3K\/AKT signalling cascades in Parkinson\u2019s disease.","volume":"4","author":"Jha","year":"2015","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"noi180098r25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"issue":"25","key":"noi180098r26","doi-asserted-by":"publisher","first-page":"18018","DOI":"10.1074\/jbc.M610949200","article-title":"Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance.","volume":"282","author":"Herschkovitz","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"noi180098r27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2009.11.003","article-title":"Irs1 serine 307 promotes insulin sensitivity in mice.","volume":"11","author":"Copps","year":"2010","journal-title":"Cell Metab"},{"issue":"5","key":"noi180098r28","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1074\/jbc.M308631200","article-title":"Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling.","volume":"279","author":"Giraud","year":"2004","journal-title":"J Biol Chem"},{"issue":"50","key":"noi180098r29","doi-asserted-by":"publisher","first-page":"46912","DOI":"10.1074\/jbc.C100483200","article-title":"5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside.","volume":"276","author":"Jakobsen","year":"2001","journal-title":"J Biol Chem"},{"key":"noi180098r31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2017.12.049","article-title":"Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson\u2019s disease.","volume":"666","author":"Sekar","year":"2018","journal-title":"Neurosci Lett"},{"issue":"4","key":"noi180098r32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013associated A\u00df oligomers.","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"noi180098r33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-\u00df plaque and glial pathology in a mouse model of Alzheimer\u2019s disease.","volume":"15","author":"Long-Smith","year":"2013","journal-title":"Neuromolecular Med"},{"issue":"2","key":"noi180098r34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JIM.0000000000000129","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.","volume":"63","author":"Xu","year":"2015","journal-title":"J Investig Med"},{"issue":"2","key":"noi180098r35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease.","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J"},{"issue":"4","key":"noi180098r36","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"issue":"6","key":"noi180098r37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/acel.2017.16.issue-6","article-title":"In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles.","volume":"16","author":"Eitan","year":"2017","journal-title":"Aging Cell"},{"issue":"3","key":"noi180098r38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jnc.2014.128.issue-3","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.","volume":"128","author":"Sharma","year":"2014","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"noi180098r39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2015.02.017","article-title":"Brain GLP-1 and insulin sensitivity.","volume":"418","author":"Sandoval","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"22","key":"noi180098r40","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1089\/neu.2015.4229","article-title":"Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats.","volume":"33","author":"Yu","year":"2016","journal-title":"J Neurotrauma"},{"issue":"5","key":"noi180098r41","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/brain\/awx044","article-title":"Insulin resistance and exendin-4 treatment for multiple system atrophy.","volume":"140","author":"Bassil","year":"2017","journal-title":"Brain"},{"issue":"10103","key":"noi180098r42","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial.","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"noi180098r44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"noi180098r45","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological guidelines to study extracellular vesicles.","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ Res"},{"issue":"1","key":"noi180098r46","doi-asserted-by":"publisher","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.","volume":"2","author":"Witwer","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"noi180098r47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes.","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front Neurosci"},{"key":"noi180098r48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fimmu.2015.00050","article-title":"Methods for extracellular vesicles isolation in a hospital setting.","volume":"6","author":"S\u00e1enz-Cuesta","year":"2015","journal-title":"Front Immunol"},{"key":"noi180098r49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neuint.2017.05.017","article-title":"ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson\u2019s disease like-phenotypes.","volume":"108","author":"Singh","year":"2017","journal-title":"Neurochem Int"},{"issue":"5","key":"noi180098r50","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s11064-017-2184-1","article-title":"Intranasal administration of GDNF protects against neural apoptosis in a rat model of Parkinson\u2019s disease through PI3K\/Akt\/GSK3\u00df pathway.","volume":"42","author":"Yue","year":"2017","journal-title":"Neurochem Res"},{"issue":"3","key":"noi180098r51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00125-004-1327-5","article-title":"Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells.","volume":"47","author":"Wang","year":"2004","journal-title":"Diabetologia"},{"key":"noi180098r52","doi-asserted-by":"publisher","first-page":"12898","DOI":"10.1038\/srep12898","article-title":"Effects of exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro.","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"issue":"8","key":"noi180098r53","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.2337\/dc12-2469","article-title":"Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.","volume":"36","author":"Ceriello","year":"2013","journal-title":"Diabetes Care"},{"key":"noi180098r54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neuroscience.2012.09.025","article-title":"Exendin-4 improved rat cortical neuron survival under oxygen\/glucose deprivation through PKA pathway.","volume":"226","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"issue":"5","key":"noi180098r55","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1248\/bpb.b14-00505","article-title":"The glucagon-like peptide-1 analogue liraglutide inhibits oxidative stress and inflammatory response in the liver of rats with diet-induced non-alcoholic fatty liver disease.","volume":"38","author":"Gao","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"noi180098r56","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","article-title":"Akt as a victim, villain and potential hero in Parkinson\u2019s disease pathophysiology and treatment.","volume":"31","author":"Greene","year":"2011","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"noi180098r57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2011.07.003","article-title":"Age and a-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt\/PKB signaling.","volume":"44","author":"Kim","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"53","key":"noi180098r58","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","article-title":"RTP801 is induced in Parkinson\u2019s disease and mediates neuron death by inhibiting Akt phosphorylation\/activation.","volume":"28","author":"Malagelada","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"noi180098r59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22383","article-title":"Dopaminergic pathway reconstruction by Akt\/Rheb-induced axon regeneration.","volume":"70","author":"Kim","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"noi180098r60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/toxsci\/kfu211","article-title":"Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis.","volume":"143","author":"Zhou","year":"2015","journal-title":"Toxicol Sci"},{"issue":"1","key":"noi180098r61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbrc.2009.11.022","article-title":"AMP-activated protein kinase is activated in Parkinson\u2019s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","volume":"391","author":"Choi","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"noi180098r62","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/jnr.v90.9","article-title":"Cooperative action of JNK and AKT\/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells.","volume":"90","author":"Rodr\u00edguez-Blanco","year":"2012","journal-title":"J Neurosci Res"},{"issue":"4","key":"noi180098r63","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1172\/JCI61332","article-title":"Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT\/mTOR signaling.","volume":"122","author":"Selvaraj","year":"2012","journal-title":"J Clin Invest"},{"issue":"4","key":"noi180098r64","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3892\/ijmm.2013.1280","article-title":"Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson\u2019s disease.","volume":"31","author":"Jiang","year":"2013","journal-title":"Int J Mol Med"},{"issue":"3","key":"noi180098r65","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson\u2019s disease.","volume":"30","author":"Malagelada","year":"2010","journal-title":"J Neurosci"},{"issue":"5","key":"noi180098r66","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","article-title":"TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.","volume":"69","author":"Copp","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"noi180098r67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/JME-15-0264","article-title":"Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation.","volume":"56","author":"Feng","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"noi180098r68","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.hlc.2016.07.006","article-title":"Exenatide regulates substrate preferences through the p38? MAPK pathway after ischaemia\/reperfusion injury in a rat heart.","volume":"26","author":"Zheng","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"5","key":"noi180098r69","first-page":"4030","article-title":"Brain GLP-1\/IGF-1 signaling and autophagy mediate exendin-4 protection against apoptosis in type 2 diabetic rats.","volume":"55","author":"Candeias","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"noi180098r70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2337\/db10-0021","article-title":"Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner.","volume":"60","author":"Mukai","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"noi180098r71","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.","volume":"113","author":"Li","year":"2010","journal-title":"J Neurochem"},{"issue":"6","key":"noi180098r72","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1159\/000374027","article-title":"Exendin-4 promotes beta cell proliferation via PI3k\/Akt signalling pathway.","volume":"35","author":"Wang","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"noi180098r73","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/jnc.13930","article-title":"Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain.","volume":"140","author":"Jones","year":"2017","journal-title":"J Neurochem"},{"key":"noi180098r74","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1038\/ncomms9543","article-title":"Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward.","volume":"6","author":"Stouffer","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"noi180098r75","doi-asserted-by":"publisher","first-page":"pyv024","DOI":"10.1093\/ijnp\/pyv024","article-title":"Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents.","volume":"18","author":"Baladi","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"noi180098r76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mcn.2015.10.005","article-title":"Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level.","volume":"70","author":"Yang","year":"2016","journal-title":"Mol Cell Neurosci"},{"issue":"10","key":"noi180098r77","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"noi180098r78","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1073\/pnas.90.8.3471","article-title":"A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression.","volume":"90","author":"Kim","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"noi180098r79","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease.","volume":"24","author":"Yun","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"noi180098r80","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1096\/fj.201600756R","article-title":"Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer\u2019s disease.","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J"},{"issue":"3","key":"noi180098r81","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer disease.","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann Neurol"},{"key":"noi180098r82","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2017.00118","article-title":"Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer\u2019s disease.","volume":"9","author":"Mullins","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"noi180098r30","unstructured":"BassilF, CanronM-H, VitalA, BezardE, FernagutP-O, MeissnerWG. Brain insulin resistance in Parkinson\u2019s disease [abstract]. Mov Disord. 2017;32(suppl 2). http:\/\/www.mdsabstracts.org\/abstract\/brain-insulin-resistance-in-parkinsons-disease\/. Accessed November 26, 2018."},{"key":"noi180098r43","unstructured":"clinicaltrials.gov. A Randomised, Double Blind, Placebo Controlled, Single Centre, 60 Week Trial of Exenatide Once Weekly for the Treatment of Moderate Severity Parkinson's Disease. NCT01981242. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01981242. Accessed November 27, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/4\/420\/17436052\/jamaneurology_athauda_2019_oi_180098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:58:07Z","timestamp":1720907887000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.4304"}},"subtitle":["A Secondary Analysis of the Exenatide-PD Trial"],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.4304","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}